ConductScience.org, home

Paper39635124

IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection.

Diniz-Lima I and 13 others. iScience, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection. Papers, record 39635124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection.
PubMed
Journal
iScience
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.62, provisional
iCite
Revised in PubMed
2024-12-07
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Diniz-Lima IIsrael
2Gomes AAriel
3Medeiros MMayck
4Guimarães-de-Oliveira JCJoyce Cristina
5Ferreira-Dos-Santos IMIdália Maria
6Barbosa da Silva-Junior EElias
7Morrot AAlexandre
8Nascimento DODanielle Oliveira
9Freire-de-Lima LLeonardo
10de Brito-Gitirana LLycia
11Cruz FFFernanda Ferreira
12Decote-Ricardo DDebora
13Leonel de Matos Guedes HHerbert
14Freire-de-Lima CGCelio Geraldo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127351934IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema.Am J Respir Cell Mol Biol2016https://conductscience.org/library/papers/27351934PubMed
229793796Emerging IL-12 family cytokines in the fight against fungal infections.Cytokine2018https://conductscience.org/library/papers/29793796PubMed
319635827Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.Infect Immun2009https://conductscience.org/library/papers/19635827PubMed
416393998IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12.J Immunol2006https://conductscience.org/library/papers/16393998PubMed
534576780Titan Cells and Yeast Forms of Cryptococcus neoformans and Cryptococcus gattii Are Recognized by GXMR-CAR.Microorganisms2021https://conductscience.org/library/papers/34576780PubMed
630852797Cryptococcus gattii VGII isolated from native forest and river in Northern Brazil.Braz J Microbiol2019https://conductscience.org/library/papers/30852797PubMed
720585559Cryptococcal cell morphology affects host cell interactions and pathogenicity.PLoS Pathog2010https://conductscience.org/library/papers/20585559PubMed
835169117IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence.Nat Commun2022https://conductscience.org/library/papers/35169117PubMed
931813737The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections.Wilderness Environ Med2020https://conductscience.org/library/papers/31813737PubMed
109093628The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis.Trans R Soc Trop Med Hyg1997https://conductscience.org/library/papers/9093628PubMed
1136091010IL-22 regulates endometrial regeneration by enhancing tight junctions and orchestrating extracellular matrix.Front Immunol2022https://conductscience.org/library/papers/36091010PubMed
1221291588Risk factors for Cryptococcus gattii infection, British Columbia, Canada.Emerg Infect Dis2011https://conductscience.org/library/papers/21291588PubMed
1338786693Inhibition of Microbicidal Activity of Canine Macrophages DH82 Cell Line by Capsular Polysaccharides from Cryptococcus neoformans.J Fungi (Basel)2024https://conductscience.org/library/papers/38786693PubMed
1422246551Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.Lung2012https://conductscience.org/library/papers/22246551PubMed
1531275938Immunomodulatory Role of Capsular Polysaccharides Constituents of Cryptococcus neoformans.Front Med (Lausanne)2019https://conductscience.org/library/papers/31275938PubMed
1629184017Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species.mBio2017https://conductscience.org/library/papers/29184017PubMed
1729467743Genotypic and Phenotypic Diversity of Cryptococcus gattii VGII Clinical Isolates and Its Impact on Virulence.Front Microbiol2018https://conductscience.org/library/papers/29467743PubMed
1822544904Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections.Eukaryot Cell2012https://conductscience.org/library/papers/22544904PubMed
1921843086Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy.Immunotherapy2011https://conductscience.org/library/papers/21843086PubMed
2012010985Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.Infect Immun2002https://conductscience.org/library/papers/12010985PubMed

See all 83 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41929258Interleukin-23 in lung and airway diseases: from pathogenesis to precision-guided therapeutic targeting.Front Pharmacol2026https://conductscience.org/library/papers/41929258PubMed
41258798Oral L-Arginine treatment attenuates Cryptococcus neoformans extrapulmonary dissemination and disease progression.Virulence2025https://conductscience.org/library/papers/41258798PubMed
41156732The Capsular Polysaccharides GXM and GXMGal from Cryptococcus neoformans Modulate Macrophages Infected with Leishmania major.Microorganisms2025https://conductscience.org/library/papers/41156732PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39635124

GET https://conductscience.org/api/papers/v1/39635124/references?page=2